<DOC>
	<DOC>NCT00990106</DOC>
	<brief_summary>The purpose of this study is to determine whether prazosin will: - reduce the incidence of nightmares and sleep disturbance - increase functioning and sense of well being in combat-trauma exposed Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Veterans.</brief_summary>
	<brief_title>Augmentation Trial of Prazosin for Post-Traumatic Stress Disorder (PTSD)</brief_title>
	<detailed_description>This is a 15-week randomized parallel design, double-blind, placebo-controlled augmentation trial of prazosin to evaluate the efficacy and tolerability of prazosin augmentation in the treatment of PTSD trauma-related nightmares, sleep disturbance, global function and sense of well-being, and other clinical features and comorbidities of PTSD. Participants will be 210 OIF/OEF soldiers and veterans who have suffered war zone trauma. Participants will be randomized 1:1 to prazosin or placebo and all previous psychotropic medications and/or psychotherapy will be maintained constant. Randomization will be stratified by site and use of an antidepressant.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders, Traumatic</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
	<mesh_term>Combat Disorders</mesh_term>
	<mesh_term>Prazosin</mesh_term>
	<criteria>Inclusion Criteria Age &gt;18 years; Clear evidence of exposure to one or more war zone trauma events sufficient to satisfy DSMIV criterion A1 for diagnosis of PTSD; DSMIV diagnosis of PTSD derived from the CAPS; CAPS total score &gt;50; CAPS Recurrent Distressing Dreams item score &gt;5 (of maximum score of 8); stable dose of nonexclusionary medications and psychotherapeutic treatment for at least 4 weeks prior to randomization; good general medical health. Female participants must agree to use a reliable form of birth control during the study. Exclusion Criteria Psychiatric/Behavioral meets DSMIV criteria for current schizophrenia, schizoaffective disorder, psychotic disorder, delirium, or any DSMIV cognitive disorder; substance dependence disorder within 3 months or any current substance dependence; current cocaine or stimulant abuse; severe psychiatric instability or severe situational life crises, including evidence of being actively suicidal or homicidal, or any behavior which poses an immediate danger to patient or others. Medical acute or unstable chronic medical illness, including unstable angina, recent myocardial infarction (within 6 months), congestive heart failure, preexisting hypotension or orthostatic hypotension, chronic renal or hepatic failure, pancreatitis, Meniere's disease, benign positional vertigo; narcolepsy, or diagnosed sleep apnea; allergy or previous adverse reaction to prazosin or other alpha1 antagonist.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>posttraumatic stress disorder</keyword>
	<keyword>PTSD</keyword>
	<keyword>nightmares</keyword>
	<keyword>prazosin</keyword>
	<keyword>sleep disturbance</keyword>
	<keyword>combat trauma</keyword>
</DOC>